Aadi Biosciences, Inc.(AADI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AADI Aadi Biosciences, Inc.

Market Closed 03-18 16:00:00 EDT

2.05

+0.00

0.00%

High2.05	Low2.05	Vol0.00
Open2.05	D1 Closing2.05	Amplitude0.00%
Mkt Cap94.89M	Tradable Cap59.99M	Total Shares46.29M
T/O163.75K	T/O Rate0.00%	Tradable Shares29.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AADI","market":"US","secType":"STK","nameCN":"Aadi Biosciences, Inc.","latestPrice":2.05,"timestamp":1742328000000,"preClose":2.05,"halted":8,"volume":0,"delay":0,"floatShares":29262500,"shares":46288600,"eps":-2.284728,"marketStatus":"Market Closed","change":0,"latestTime":"03-18 16:00:00 EDT","open":2.05,"high":2.05,"low":2.05,"amount":163751.2463115,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.284728,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"symbolChange":{"newSymbol":"WHWK","executeDate":"2025-03-19"},"adr":0,"exchange":"NASDAQ","adjPreClose":2.05,"volumeRatio":0},"requestUrl":"/m/hq/s/AADI","defaultTab":"news","newsList":[{"id":"2520363955","title":"BRIEF-Aadi Bioscience Inc changes name to Whitehawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2520363955","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520363955?lang=en_us&edition=fundamental","pubTime":"2025-03-19 05:58","pubTimestamp":1742335129,"startTime":"0","endTime":"0","summary":"BRIEF-Aadi Bioscience Inc changes name to Whitehawk TherapeuticsMarch 18 (Reuters) - Aadi Bioscience Inc AADI.O:AADI BIOSCIENCE INC:  CHANGES ITS NAME TO WHITEHAWK THERAPEUTICSAADI BIOSCIENCE INC: COM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q11EY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","BK4139","AADI"],"gpt_icon":0},{"id":"2520934564","title":"Aadi Bioscience Inc: Company Shares to Trade on Nasdaq Under Symbol \"Whwk\" Effective March 19, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520934564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520934564?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:15","pubTimestamp":1742328946,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q11EY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AADI","WHWK","BK4139"],"gpt_icon":0},{"id":"2520584934","title":"Aadi Bioscience Inc:  Changes Its Name to WhiteHawk Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2520584934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520584934?lang=en_us&edition=fundamental","pubTime":"2025-03-19 04:15","pubTimestamp":1742328946,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q11EY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WHWK","AADI","BK4139"],"gpt_icon":0},{"id":"2520994525","title":"Aadi Bioscience Inc  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520994525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520994525?lang=en_us&edition=fundamental","pubTime":"2025-03-17 20:45","pubTimestamp":1742215546,"startTime":"0","endTime":"0","summary":"Aadi Bioscience Inc  expected to post a loss of22cents a share - Earnings Preview Aadi Bioscience Inc AADI.OQ AADI.O is expected to show a rise in quarterly revenue when it reports  results on March 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL8N3Q00YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AADI","WHWK"],"gpt_icon":0},{"id":"2517484096","title":"Aadi Bioscience Inc  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484096","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484096?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:34","pubTimestamp":1741350861,"startTime":"0","endTime":"0","summary":"Aadi Bioscience Inc  expected to post a loss of22cents a share - Earnings Preview Aadi Bioscience Inc AADI.OQ AADI.O is expected to show a rise in quarterly revenue when it reports  results on March 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ0YK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AADI"],"gpt_icon":0},{"id":"2517398468","title":"BRIEF-Aadi Bioscience Announces Closing of $100 Million PIPE Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517398468","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517398468?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:54","pubTimestamp":1741125252,"startTime":"0","endTime":"0","summary":"BRIEF-Aadi Bioscience Announces Closing of $100 Million PIPE FinancingMarch 4 (Reuters) - Aadi Bioscience Inc AADI.O:AADI BIOSCIENCE ANNOUNCES CLOSING OF $100 MILLION PIPE FINANCINGSource text: ID:nPn5nfGdtaFurther company coverage: AADI.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA6N1RC1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AADI"],"gpt_icon":0},{"id":"2517986760","title":"Aadi Bioscience Announces Closing of $100 Million Pipe Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517986760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517986760?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:05","pubTimestamp":1741122303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nTUA6N1RC1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AADI"],"gpt_icon":0},{"id":"2517535989","title":"Press Release: Aadi Bioscience Announces Closing of $100 Million PIPE Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2517535989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517535989?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:05","pubTimestamp":1741122300,"startTime":"0","endTime":"0","summary":"MORRISTOWN, N.J., March 4, 2025 /PRNewswire/ -- Aadi Bioscience, Inc.  , an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer treatment, today announced the closing of its previously announced private placement. The private placement was led by Ally Bridge Group, with participation from new investors OrbiMed,  Invus, Kalehua Capital and other accredited investors, Tae Han,  co-founder of ProfoundBio, as well as existing investors, including Avoro Capital, KVP Capital and Acuta Capital Partners, for total gross proceeds of approximately $100 million.Jefferies LLC acted as exclusive placement agent for the private placement.This press release shall not constitute an offer to sell or a solicitation of an offer to buy Aadi's Common Stock, nor shall there be any offer, solicitation, or sale of Aadi's Common Stock in any jurisdiction in which such offer, solicitation or sale would","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","R","AADI","BK4022","PIPE"],"gpt_icon":0},{"id":"2516863457","title":"BRIEF-Aadi Bioscience Announces Approval Of All Proposals At Special Meeting Of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2516863457","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516863457?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:40","pubTimestamp":1741012829,"startTime":"0","endTime":"0","summary":"BRIEF-Aadi Bioscience Announces Approval Of All Proposals At Special Meeting Of StockholdersMarch 3 (Reuters) - Aadi Bioscience Inc AADI.O:AADI BIOSCIENCE ANNOUNCES APPROVAL OF ALL PROPOSALS AT SPECIA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA82ZZPH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AADI","BK4139"],"gpt_icon":0},{"id":"2516633931","title":"Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633931?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006807,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nTUA82ZZPH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AADI"],"gpt_icon":0},{"id":"2516633457","title":"Press Release: Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2516633457","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516633457?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"MORRISTOWN, N.J., March 3, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. , an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer treatment, today announced that the Company's stockholders have approved all proposals voted on at the Company's Special Meeting of Stockholders  held on February 28, 2025.Divestiture Proposal. The approval of the sale by Aadi to KAKEN INVESTMENTS INC.  of 100% of the outstanding shares of capital stock of Aadi Subsidiary, Inc.  and thereby all or substantially all of Aadi's assets related to its FYARRO   program .Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people living with difficult-to-treat cancers. More information on the Company is available on the Aadi website at www.aadibio.com and connect with us on LinkedIn.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","R","BK4022","AADI","BK4232"],"gpt_icon":0},{"id":"2512547541","title":"Aadi Bioscience Appoints David Dornan, Phd, as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2512547541","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512547541?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:00","pubTimestamp":1739883621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nTUA3V4VG1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AADI","BK4139"],"gpt_icon":0},{"id":"2512154039","title":"Press Release: Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2512154039","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512154039?lang=en_us&edition=fundamental","pubTime":"2025-02-18 21:00","pubTimestamp":1739883600,"startTime":"0","endTime":"0","summary":"Seasoned Oncology Leader Brings Extensive ADC Expertise to Support Company's New Pipeline. MORRISTOWN, N.J., Feb. 18, 2025 /PRNewswire/ -- Aadi Bioscience, Inc.  today announced the appointment of David Dornan, PhD as the Company's Chief Scientific Officer . Dr. Dornan contributes more than two decades of experience in oncology drug discovery and development, with deep expertise in antibody-drug conjugates  and other targeted cancer therapies.\"David's extensive experience in ADC development and track record of translating novel oncology discoveries into clinical programs make him an ideal leader as we seek to rapidly advance our newly in-licensed ADC portfolio,\" said David Lennon, PhD, President and CEO of Aadi Bioscience. \"We are thrilled to welcome David to our growing ADC-experienced team, which also boasts board members from leading ADC companies, Behzad Aghazedeh, former CEO and Executive Chair of Immunomedics, and recently appointed Baiteng Zhao, PhD, co-founder and former Chairm","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","R","BK4232","AADI","BK4022"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aadibio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":-0.1494},{"period":"ytd","weight":-0.3502}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.179486},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.0383},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.212518},{"month":4,"riseRate":0.5,"avgChangeRate":0.006696},{"month":5,"riseRate":0.833333,"avgChangeRate":0.198965},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.098715},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.019883},{"month":8,"riseRate":0.571429,"avgChangeRate":0.031928},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.003937},{"month":10,"riseRate":0,"avgChangeRate":-0.14358},{"month":11,"riseRate":0.714286,"avgChangeRate":0.092547},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.101414}],"exchange":"NASDAQ","name":"Aadi Biosciences, Inc.","nameEN":"Aadi Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aadi Biosciences, Inc.(AADI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aadi Biosciences, Inc.(AADI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aadi Biosciences, Inc.,AADI,Aadi Biosciences, Inc.股票,Aadi Biosciences, Inc.股票老虎,Aadi Biosciences, Inc.股票老虎国际,Aadi Biosciences, Inc.行情,Aadi Biosciences, Inc.股票行情,Aadi Biosciences, Inc.股价,Aadi Biosciences, Inc.股市,Aadi Biosciences, Inc.股票价格,Aadi Biosciences, Inc.股票交易,Aadi Biosciences, Inc.股票购买,Aadi Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aadi Biosciences, Inc.(AADI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aadi Biosciences, Inc.(AADI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction